| UniProt ID | BAZ1B_HUMAN | |
|---|---|---|
| UniProt AC | Q9UIG0 | |
| Protein Name | Tyrosine-protein kinase BAZ1B | |
| Gene Name | BAZ1B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1483 | |
| Subcellular Localization | Nucleus . Accumulates in pericentromeric heterochromatin during replication. Targeted to replication foci throughout S phase via its association with PCNA. | |
| Protein Description | Atypical tyrosine-protein kinase that plays a central role in chromatin remodeling and acts as a transcription regulator. Involved in DNA damage response by phosphorylating 'Tyr-142' of histone H2AX (H2AXY142ph). H2AXY142ph plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Essential component of the WICH complex, a chromatin remodeling complex that mobilizes nucleosomes and reconfigures irregular chromatin to a regular nucleosomal array structure. The WICH complex regulates the transcription of various genes, has a role in RNA polymerase I and RNA polymerase III transcription, mediates the histone H2AX phosphorylation at 'Tyr-142', and is involved in the maintenance of chromatin structures during DNA replication processes. In the complex, it mediates the recruitment of the WICH complex to replication foci during DNA replication.. | |
| Protein Sequence | MAPLLGRKPFPLVKPLPGEEPLFTIPHTQEAFRTREEYEARLERYSERIWTCKSTGSSQLTHKEAWEEEQEVAELLKEEFPAWYEKLVLEMVHHNTASLEKLVDTAWLEIMTKYAVGEECDFEVGKEKMLKVKIVKIHPLEKVDEEATEKKSDGACDSPSSDKENSSQIAQDHQKKETVVKEDEGRRESINDRARRSPRKLPTSLKKGERKWAPPKFLPHKYDVKLQNEDKIISNVPADSLIRTERPPNKEIVRYFIRHNALRAGTGENAPWVVEDELVKKYSLPSKFSDFLLDPYKYMTLNPSTKRKNTGSPDRKPSKKSKTDNSSLSSPLNPKLWCHVHLKKSLSGSPLKVKNSKNSKSPEEHLEEMMKMMSPNKLHTNFHIPKKGPPAKKPGKHSDKPLKAKGRSKGILNGQKSTGNSKSPKKGLKTPKTKMKQMTLLDMAKGTQKMTRAPRNSGGTPRTSSKPHKHLPPAALHLIAYYKENKDREDKRSALSCVISKTARLLSSEDRARLPEELRSLVQKRYELLEHKKRWASMSEEQRKEYLKKKREELKKKLKEKAKERREKEMLERLEKQKRYEDQELTGKNLPAFRLVDTPEGLPNTLFGDVAMVVEFLSCYSGLLLPDAQYPITAVSLMEALSADKGGFLYLNRVLVILLQTLLQDEIAEDYGELGMKLSEIPLTLHSVSELVRLCLRRSDVQEESEGSDTDDNKDSAAFEDNEVQDEFLEKLETSEFFELTSEEKLQILTALCHRILMTYSVQDHMETRQQMSAELWKERLAVLKEENDKKRAEKQKRKEMEAKNKENGKVENGLGKTDRKKEIVKFEPQVDTEAEDMISAVKSRRLLAIQAKKEREIQEREMKVKLERQAEEERIRKHKAAAEKAFQEGIAKAKLVMRRTPIGTDRNHNRYWLFSDEVPGLFIEKGWVHDSIDYRFNHHCKDHTVSGDEDYCPRSKKANLGKNASMNTQHGTATEVAVETTTPKQGQNLWFLCDSQKELDELLNCLHPQGIRESQLKERLEKRYQDIIHSIHLARKPNLGLKSCDGNQELLNFLRSDLIEVATRLQKGGLGYVEETSEFEARVISLEKLKDFGECVIALQASVIKKFLQGFMAPKQKRRKLQSEDSAKTEEVDEEKKMVEEAKVASALEKWKTAIREAQTFSRMHVLLGMLDACIKWDMSAENARCKVCRKKGEDDKLILCDECNKAFHLFCLRPALYEVPDGEWQCPACQPATARRNSRGRNYTEESASEDSEDDESDEEEEEEEEEEEEEDYEVAGLRLRPRKTIRGKHSVIPPAARSGRRPGKKPHSTRRSQPKAPPVDDAEVDELVLQTKRSSRRQSLELQKCEEILHKIVKYRFSWPFREPVTRDEAEDYYDVITHPMDFQTVQNKCSCGSYRSVQEFLTDMKQVFTNAEVYNCRGSHVLSCMVKTEQCLVALLHKHLPGHPYVRRKRKKFPDRLAEDEGDSEPEAVGQSRGRRQKK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Acetylation | MAPLLGRKPFPLVKP CCCCCCCCCCCCCCC | 49.57 | 26051181 | |
| 8 | Ubiquitination | MAPLLGRKPFPLVKP CCCCCCCCCCCCCCC | 49.57 | 23000965 | |
| 14 | Acetylation | RKPFPLVKPLPGEEP CCCCCCCCCCCCCCC | 48.82 | 26051181 | |
| 14 | Ubiquitination | RKPFPLVKPLPGEEP CCCCCCCCCCCCCCC | 48.82 | 23000965 | |
| 45 | Phosphorylation | YEARLERYSERIWTC HHHHHHHHHHCEEEE | 12.90 | 23312004 | |
| 46 | Phosphorylation | EARLERYSERIWTCK HHHHHHHHHCEEEEC | 26.98 | 23312004 | |
| 53 | Ubiquitination | SERIWTCKSTGSSQL HHCEEEECCCCCCCC | 43.61 | 29967540 | |
| 54 | Phosphorylation | ERIWTCKSTGSSQLT HCEEEECCCCCCCCC | 39.90 | 23312004 | |
| 55 | Phosphorylation | RIWTCKSTGSSQLTH CEEEECCCCCCCCCC | 26.95 | 23312004 | |
| 57 | Phosphorylation | WTCKSTGSSQLTHKE EEECCCCCCCCCCHH | 18.26 | 23312004 | |
| 58 | Phosphorylation | TCKSTGSSQLTHKEA EECCCCCCCCCCHHH | 30.47 | 25159151 | |
| 61 | Phosphorylation | STGSSQLTHKEAWEE CCCCCCCCCHHHHHH | 24.22 | 23312004 | |
| 63 | Ubiquitination | GSSQLTHKEAWEEEQ CCCCCCCHHHHHHHH | 43.84 | 29967540 | |
| 77 | Ubiquitination | QEVAELLKEEFPAWY HHHHHHHHHHCHHHH | 68.75 | 29967540 | |
| 126 | Acetylation | ECDFEVGKEKMLKVK CCCCCCCCCCEEEEE | 60.38 | 26051181 | |
| 126 | Ubiquitination | ECDFEVGKEKMLKVK CCCCCCCCCCEEEEE | 60.38 | 33845483 | |
| 128 | Ubiquitination | DFEVGKEKMLKVKIV CCCCCCCCEEEEEEE | 53.68 | - | |
| 136 | Ubiquitination | MLKVKIVKIHPLEKV EEEEEEEEEEECHHC | 38.48 | 29967540 | |
| 142 | Acetylation | VKIHPLEKVDEEATE EEEEECHHCCHHHHH | 63.77 | 26051181 | |
| 142 | Ubiquitination | VKIHPLEKVDEEATE EEEEECHHCCHHHHH | 63.77 | 33845483 | |
| 148 | Phosphorylation | EKVDEEATEKKSDGA HHCCHHHHHCCCCCC | 52.17 | 30576142 | |
| 150 | Ubiquitination | VDEEATEKKSDGACD CCHHHHHCCCCCCCC | 53.90 | 33845483 | |
| 151 | Acetylation | DEEATEKKSDGACDS CHHHHHCCCCCCCCC | 47.77 | 7408827 | |
| 152 | Phosphorylation | EEATEKKSDGACDSP HHHHHCCCCCCCCCC | 52.96 | 22167270 | |
| 158 | Phosphorylation | KSDGACDSPSSDKEN CCCCCCCCCCCCCCC | 26.94 | 22167270 | |
| 160 | Phosphorylation | DGACDSPSSDKENSS CCCCCCCCCCCCCHH | 55.94 | 22167270 | |
| 161 | Phosphorylation | GACDSPSSDKENSSQ CCCCCCCCCCCCHHH | 56.96 | 22167270 | |
| 163 | Acetylation | CDSPSSDKENSSQIA CCCCCCCCCCHHHHH | 61.82 | 25953088 | |
| 166 | Phosphorylation | PSSDKENSSQIAQDH CCCCCCCHHHHHHHH | 25.39 | 22167270 | |
| 167 | Phosphorylation | SSDKENSSQIAQDHQ CCCCCCHHHHHHHHH | 36.87 | 17525332 | |
| 175 | "N6,N6-dimethyllysine" | QIAQDHQKKETVVKE HHHHHHHHHHHEECC | 49.51 | - | |
| 175 | Acetylation | QIAQDHQKKETVVKE HHHHHHHHHHHEECC | 49.51 | 7408839 | |
| 175 | Methylation | QIAQDHQKKETVVKE HHHHHHHHHHHEECC | 49.51 | - | |
| 181 | "N6,N6-dimethyllysine" | QKKETVVKEDEGRRE HHHHHEECCCCCCHH | 55.93 | - | |
| 181 | Methylation | QKKETVVKEDEGRRE HHHHHEECCCCCCHH | 55.93 | - | |
| 189 | Phosphorylation | EDEGRRESINDRARR CCCCCHHHHHHHHHC | 25.53 | 23401153 | |
| 197 | Phosphorylation | INDRARRSPRKLPTS HHHHHHCCCCCCCCC | 24.41 | 25159151 | |
| 203 | Phosphorylation | RSPRKLPTSLKKGER CCCCCCCCCCCCCCC | 58.07 | 30266825 | |
| 204 | Phosphorylation | SPRKLPTSLKKGERK CCCCCCCCCCCCCCC | 35.93 | 30266825 | |
| 207 | Ubiquitination | KLPTSLKKGERKWAP CCCCCCCCCCCCCCC | 71.89 | 24816145 | |
| 216 | Acetylation | ERKWAPPKFLPHKYD CCCCCCCCCCCCCCE | 59.48 | 26051181 | |
| 221 | Acetylation | PPKFLPHKYDVKLQN CCCCCCCCCEEECCC | 41.00 | 26051181 | |
| 221 | Ubiquitination | PPKFLPHKYDVKLQN CCCCCCCCCEEECCC | 41.00 | 29967540 | |
| 222 | Phosphorylation | PKFLPHKYDVKLQNE CCCCCCCCEEECCCC | 23.96 | - | |
| 225 | Sumoylation | LPHKYDVKLQNEDKI CCCCCEEECCCCCCC | 41.27 | - | |
| 225 | Sumoylation | LPHKYDVKLQNEDKI CCCCCEEECCCCCCC | 41.27 | - | |
| 225 | Ubiquitination | LPHKYDVKLQNEDKI CCCCCEEECCCCCCC | 41.27 | 33845483 | |
| 231 | Acetylation | VKLQNEDKIISNVPA EECCCCCCCCCCCCH | 35.44 | 25953088 | |
| 231 | Ubiquitination | VKLQNEDKIISNVPA EECCCCCCCCCCCCH | 35.44 | 33845483 | |
| 234 | Phosphorylation | QNEDKIISNVPADSL CCCCCCCCCCCHHHH | 34.94 | - | |
| 240 | Phosphorylation | ISNVPADSLIRTERP CCCCCHHHHHCCCCC | 28.00 | 24719451 | |
| 250 | Acetylation | RTERPPNKEIVRYFI CCCCCCCHHHHHHHH | 55.37 | 26051181 | |
| 250 | Ubiquitination | RTERPPNKEIVRYFI CCCCCCCHHHHHHHH | 55.37 | 24816145 | |
| 266 | Phosphorylation | HNALRAGTGENAPWV HCCHHCCCCCCCCCE | 40.10 | 20068231 | |
| 280 | Acetylation | VVEDELVKKYSLPSK EECHHHHHHCCCCCC | 59.63 | 26051181 | |
| 280 | Ubiquitination | VVEDELVKKYSLPSK EECHHHHHHCCCCCC | 59.63 | 29967540 | |
| 281 | Ubiquitination | VEDELVKKYSLPSKF ECHHHHHHCCCCCCH | 32.37 | - | |
| 282 | Phosphorylation | EDELVKKYSLPSKFS CHHHHHHCCCCCCHH | 15.10 | - | |
| 283 | Phosphorylation | DELVKKYSLPSKFSD HHHHHHCCCCCCHHH | 42.56 | 19691289 | |
| 286 | Phosphorylation | VKKYSLPSKFSDFLL HHHCCCCCCHHHHHC | 52.18 | 24719451 | |
| 287 | Ubiquitination | KKYSLPSKFSDFLLD HHCCCCCCHHHHHCC | 47.12 | - | |
| 289 | Phosphorylation | YSLPSKFSDFLLDPY CCCCCCHHHHHCCHH | 31.05 | 20068231 | |
| 296 | Phosphorylation | SDFLLDPYKYMTLNP HHHHCCHHHCCCCCC | 17.89 | 26074081 | |
| 297 | Acetylation | DFLLDPYKYMTLNPS HHHCCHHHCCCCCCC | 33.65 | 11688637 | |
| 297 | Ubiquitination | DFLLDPYKYMTLNPS HHHCCHHHCCCCCCC | 33.65 | 23000965 | |
| 297 (in isoform 1) | Ubiquitination | - | 33.65 | 21890473 | |
| 297 (in isoform 2) | Ubiquitination | - | 33.65 | 21890473 | |
| 298 | Phosphorylation | FLLDPYKYMTLNPST HHCCHHHCCCCCCCC | 6.89 | 26074081 | |
| 300 | Phosphorylation | LDPYKYMTLNPSTKR CCHHHCCCCCCCCCC | 21.94 | 26074081 | |
| 304 | Phosphorylation | KYMTLNPSTKRKNTG HCCCCCCCCCCCCCC | 45.55 | 23401153 | |
| 305 | Phosphorylation | YMTLNPSTKRKNTGS CCCCCCCCCCCCCCC | 35.80 | 23401153 | |
| 306 | Acetylation | MTLNPSTKRKNTGSP CCCCCCCCCCCCCCC | 66.76 | 25953088 | |
| 306 | Ubiquitination | MTLNPSTKRKNTGSP CCCCCCCCCCCCCCC | 66.76 | 23000965 | |
| 308 | Ubiquitination | LNPSTKRKNTGSPDR CCCCCCCCCCCCCCC | 61.49 | 23000965 | |
| 310 | Phosphorylation | PSTKRKNTGSPDRKP CCCCCCCCCCCCCCC | 41.91 | 26074081 | |
| 312 | Phosphorylation | TKRKNTGSPDRKPSK CCCCCCCCCCCCCCC | 22.91 | 25159151 | |
| 316 | Ubiquitination | NTGSPDRKPSKKSKT CCCCCCCCCCCCCCC | 62.11 | 23000965 | |
| 318 | Phosphorylation | GSPDRKPSKKSKTDN CCCCCCCCCCCCCCC | 56.61 | 28176443 | |
| 319 | Ubiquitination | SPDRKPSKKSKTDNS CCCCCCCCCCCCCCC | 70.37 | 23000965 | |
| 320 | Ubiquitination | PDRKPSKKSKTDNSS CCCCCCCCCCCCCCC | 62.62 | 23000965 | |
| 321 | Phosphorylation | DRKPSKKSKTDNSSL CCCCCCCCCCCCCCC | 44.52 | 26055452 | |
| 322 | Ubiquitination | RKPSKKSKTDNSSLS CCCCCCCCCCCCCCC | 69.63 | 23000965 | |
| 323 | Phosphorylation | KPSKKSKTDNSSLSS CCCCCCCCCCCCCCC | 47.72 | 26055452 | |
| 326 | Phosphorylation | KKSKTDNSSLSSPLN CCCCCCCCCCCCCCC | 35.15 | 25159151 | |
| 327 | Phosphorylation | KSKTDNSSLSSPLNP CCCCCCCCCCCCCCH | 38.23 | 25159151 | |
| 329 | Phosphorylation | KTDNSSLSSPLNPKL CCCCCCCCCCCCHHH | 31.68 | 30266825 | |
| 330 | Phosphorylation | TDNSSLSSPLNPKLW CCCCCCCCCCCHHHE | 38.40 | 23401153 | |
| 335 | Acetylation | LSSPLNPKLWCHVHL CCCCCCHHHEEEEEE | 54.25 | 25953088 | |
| 335 | Ubiquitination | LSSPLNPKLWCHVHL CCCCCCHHHEEEEEE | 54.25 | 23000965 | |
| 343 | Ubiquitination | LWCHVHLKKSLSGSP HEEEEEEEHHHCCCC | 25.99 | 29967540 | |
| 344 | Methylation | WCHVHLKKSLSGSPL EEEEEEEHHHCCCCC | 64.09 | 115978471 | |
| 344 | Ubiquitination | WCHVHLKKSLSGSPL EEEEEEEHHHCCCCC | 64.09 | 29967540 | |
| 345 | Phosphorylation | CHVHLKKSLSGSPLK EEEEEEHHHCCCCCC | 26.61 | 23927012 | |
| 347 | Phosphorylation | VHLKKSLSGSPLKVK EEEEHHHCCCCCCCC | 44.29 | 22167270 | |
| 349 | Phosphorylation | LKKSLSGSPLKVKNS EEHHHCCCCCCCCCC | 24.55 | 22167270 | |
| 352 | Ubiquitination | SLSGSPLKVKNSKNS HHCCCCCCCCCCCCC | 55.32 | 32015554 | |
| 359 | Phosphorylation | KVKNSKNSKSPEEHL CCCCCCCCCCHHHHH | 37.94 | 22167270 | |
| 361 | Phosphorylation | KNSKNSKSPEEHLEE CCCCCCCCHHHHHHH | 37.05 | 29255136 | |
| 374 | Phosphorylation | EEMMKMMSPNKLHTN HHHHHHHCCCCCCCC | 23.09 | 27134283 | |
| 380 | Phosphorylation | MSPNKLHTNFHIPKK HCCCCCCCCCCCCCC | 50.44 | 20068231 | |
| 386 | Ubiquitination | HTNFHIPKKGPPAKK CCCCCCCCCCCCCCC | 70.52 | 29967540 | |
| 409 | Acetylation | LKAKGRSKGILNGQK CCCCCCCCCCCCCCC | 48.92 | 71341 | |
| 416 | Acetylation | KGILNGQKSTGNSKS CCCCCCCCCCCCCCC | 51.92 | 71345 | |
| 421 | Phosphorylation | GQKSTGNSKSPKKGL CCCCCCCCCCCCCCC | 35.54 | 29888752 | |
| 423 | Phosphorylation | KSTGNSKSPKKGLKT CCCCCCCCCCCCCCC | 41.60 | 24719451 | |
| 426 | Acetylation | GNSKSPKKGLKTPKT CCCCCCCCCCCCCCH | 73.24 | 19608861 | |
| 429 | Acetylation | KSPKKGLKTPKTKMK CCCCCCCCCCCHHHH | 72.02 | 26210075 | |
| 430 | Phosphorylation | SPKKGLKTPKTKMKQ CCCCCCCCCCHHHHH | 34.75 | 24719451 | |
| 432 | Acetylation | KKGLKTPKTKMKQMT CCCCCCCCHHHHHHH | 67.04 | 26210075 | |
| 439 | Phosphorylation | KTKMKQMTLLDMAKG CHHHHHHHHHHHHHC | 22.98 | 29396449 | |
| 445 | Ubiquitination | MTLLDMAKGTQKMTR HHHHHHHHCCHHHCC | 56.72 | 29967540 | |
| 447 | Phosphorylation | LLDMAKGTQKMTRAP HHHHHHCCHHHCCCC | 25.06 | 29396449 | |
| 449 | Acetylation | DMAKGTQKMTRAPRN HHHHCCHHHCCCCCC | 41.92 | 11791593 | |
| 451 | Phosphorylation | AKGTQKMTRAPRNSG HHCCHHHCCCCCCCC | 30.62 | - | |
| 457 | Phosphorylation | MTRAPRNSGGTPRTS HCCCCCCCCCCCCCC | 39.62 | 28102081 | |
| 460 | Phosphorylation | APRNSGGTPRTSSKP CCCCCCCCCCCCCCC | 17.08 | 28102081 | |
| 465 | Phosphorylation | GGTPRTSSKPHKHLP CCCCCCCCCCCCCCC | 49.98 | - | |
| 483 | Ubiquitination | LHLIAYYKENKDRED HHHHHHHHHCCCHHH | 41.98 | 23000965 | |
| 486 | Ubiquitination | IAYYKENKDREDKRS HHHHHHCCCHHHHHH | 60.29 | 23000965 | |
| 496 | Phosphorylation | EDKRSALSCVISKTA HHHHHHHHHHHHHHH | 13.17 | 24667141 | |
| 501 | Acetylation | ALSCVISKTARLLSS HHHHHHHHHHHHCCH | 34.77 | 25953088 | |
| 501 | Malonylation | ALSCVISKTARLLSS HHHHHHHHHHHHCCH | 34.77 | 26320211 | |
| 501 | Ubiquitination | ALSCVISKTARLLSS HHHHHHHHHHHHCCH | 34.77 | 23000965 | |
| 507 | Phosphorylation | SKTARLLSSEDRARL HHHHHHCCHHHHHCC | 35.95 | 20873877 | |
| 508 | Phosphorylation | KTARLLSSEDRARLP HHHHHCCHHHHHCCH | 43.41 | 19691289 | |
| 526 | Phosphorylation | RSLVQKRYELLEHKK HHHHHHHHHHHHHHH | 20.26 | 28152594 | |
| 532 | 2-Hydroxyisobutyrylation | RYELLEHKKRWASMS HHHHHHHHHHHHCCC | 34.36 | - | |
| 532 | Ubiquitination | RYELLEHKKRWASMS HHHHHHHHHHHHCCC | 34.36 | 29967540 | |
| 537 | Phosphorylation | EHKKRWASMSEEQRK HHHHHHHCCCHHHHH | 18.84 | 28555341 | |
| 539 | Phosphorylation | KKRWASMSEEQRKEY HHHHHCCCHHHHHHH | 35.17 | 29083192 | |
| 546 | Phosphorylation | SEEQRKEYLKKKREE CHHHHHHHHHHHHHH | 27.19 | 29083192 | |
| 549 | Ubiquitination | QRKEYLKKKREELKK HHHHHHHHHHHHHHH | 55.24 | 24816145 | |
| 561 | Ubiquitination | LKKKLKEKAKERREK HHHHHHHHHHHHHHH | 64.27 | 24816145 | |
| 588 | Acetylation | EDQELTGKNLPAFRL HCCCCCCCCCCCEEE | 50.50 | 26051181 | |
| 588 | Ubiquitination | EDQELTGKNLPAFRL HCCCCCCCCCCCEEE | 50.50 | 22817900 | |
| 588 (in isoform 1) | Ubiquitination | - | 50.50 | 21890473 | |
| 588 (in isoform 2) | Ubiquitination | - | 50.50 | 21890473 | |
| 699 | Phosphorylation | VRLCLRRSDVQEESE HHHHHHCCCCCHHHC | 35.38 | 30278072 | |
| 705 | Phosphorylation | RSDVQEESEGSDTDD CCCCCHHHCCCCCCC | 46.64 | 29255136 | |
| 708 | Phosphorylation | VQEESEGSDTDDNKD CCHHHCCCCCCCCCC | 33.03 | 29255136 | |
| 710 | Phosphorylation | EESEGSDTDDNKDSA HHHCCCCCCCCCCCH | 47.12 | 29255136 | |
| 716 | Phosphorylation | DTDDNKDSAAFEDNE CCCCCCCCHHHCCCH | 24.09 | 30278072 | |
| 759 | Phosphorylation | LCHRILMTYSVQDHM HHHHHHHHHCHHHHH | 14.81 | - | |
| 760 | Phosphorylation | CHRILMTYSVQDHME HHHHHHHHCHHHHHH | 7.90 | - | |
| 774 (in isoform 2) | Ubiquitination | - | 15.57 | 21890473 | |
| 778 | Ubiquitination | QMSAELWKERLAVLK HHHHHHHHHHHHHHH | 45.65 | 21890473 | |
| 778 (in isoform 1) | Ubiquitination | - | 45.65 | 21890473 | |
| 790 | Ubiquitination | VLKEENDKKRAEKQK HHHHHHHHHHHHHHH | 56.60 | 24816145 | |
| 810 | Acetylation | AKNKENGKVENGLGK HHHHHCCCCCCCCCC | 58.94 | 30584253 | |
| 817 | Acetylation | KVENGLGKTDRKKEI CCCCCCCCCCCCHHH | 52.90 | 23749302 | |
| 826 | Sumoylation | DRKKEIVKFEPQVDT CCCHHHEEECCCCCC | 50.07 | - | |
| 826 | Sumoylation | DRKKEIVKFEPQVDT CCCHHHEEECCCCCC | 50.07 | 25114211 | |
| 826 | Ubiquitination | DRKKEIVKFEPQVDT CCCHHHEEECCCCCC | 50.07 | 24816145 | |
| 833 | Phosphorylation | KFEPQVDTEAEDMIS EECCCCCCCHHHHHH | 37.93 | 30266825 | |
| 840 | Phosphorylation | TEAEDMISAVKSRRL CCHHHHHHHHHHHHH | 22.00 | - | |
| 843 | Acetylation | EDMISAVKSRRLLAI HHHHHHHHHHHHHHH | 37.65 | 25953088 | |
| 843 | Ubiquitination | EDMISAVKSRRLLAI HHHHHHHHHHHHHHH | 37.65 | 32015554 | |
| 844 | Phosphorylation | DMISAVKSRRLLAIQ HHHHHHHHHHHHHHH | 18.94 | - | |
| 853 | Sumoylation | RLLAIQAKKEREIQE HHHHHHHHHHHHHHH | 38.50 | - | |
| 853 | 2-Hydroxyisobutyrylation | RLLAIQAKKEREIQE HHHHHHHHHHHHHHH | 38.50 | - | |
| 853 | Acetylation | RLLAIQAKKEREIQE HHHHHHHHHHHHHHH | 38.50 | 25953088 | |
| 853 | Sumoylation | RLLAIQAKKEREIQE HHHHHHHHHHHHHHH | 38.50 | 28112733 | |
| 853 | Ubiquitination | RLLAIQAKKEREIQE HHHHHHHHHHHHHHH | 38.50 | 29967540 | |
| 854 | Ubiquitination | LLAIQAKKEREIQER HHHHHHHHHHHHHHH | 66.09 | - | |
| 864 | Acetylation | EIQEREMKVKLERQA HHHHHHHHHHHHHHH | 31.31 | 19821681 | |
| 885 | Acetylation | KHKAAAEKAFQEGIA HHHHHHHHHHHHHHH | 50.18 | 25953088 | |
| 885 | Ubiquitination | KHKAAAEKAFQEGIA HHHHHHHHHHHHHHH | 50.18 | - | |
| 893 | Acetylation | AFQEGIAKAKLVMRR HHHHHHHHHEEEEEC | 44.10 | 25953088 | |
| 893 | Ubiquitination | AFQEGIAKAKLVMRR HHHHHHHHHEEEEEC | 44.10 | 29967540 | |
| 932 | Phosphorylation | EKGWVHDSIDYRFNH ECCCCCCCCCCCCCC | 11.50 | - | |
| 935 | Phosphorylation | WVHDSIDYRFNHHCK CCCCCCCCCCCCCCC | 18.55 | - | |
| 942 | Acetylation | YRFNHHCKDHTVSGD CCCCCCCCCCCCCCC | 48.46 | 26051181 | |
| 942 | Ubiquitination | YRFNHHCKDHTVSGD CCCCCCCCCCCCCCC | 48.46 | 33845483 | |
| 945 | Phosphorylation | NHHCKDHTVSGDEDY CCCCCCCCCCCCCCC | 26.88 | 23401153 | |
| 947 | Phosphorylation | HCKDHTVSGDEDYCP CCCCCCCCCCCCCCC | 41.50 | 29255136 | |
| 952 | Phosphorylation | TVSGDEDYCPRSKKA CCCCCCCCCCHHHCC | 11.42 | 29255136 | |
| 963 | Acetylation | SKKANLGKNASMNTQ HHCCCCCCCCCCCCC | 53.13 | 26051181 | |
| 966 | Phosphorylation | ANLGKNASMNTQHGT CCCCCCCCCCCCCCC | 23.20 | 29214152 | |
| 969 | Phosphorylation | GKNASMNTQHGTATE CCCCCCCCCCCCEEE | 17.19 | 21712546 | |
| 973 | Phosphorylation | SMNTQHGTATEVAVE CCCCCCCCEEEEEEE | 28.43 | 21712546 | |
| 983 | Phosphorylation | EVAVETTTPKQGQNL EEEEEECCCCCCCEE | 35.59 | - | |
| 1025 | Phosphorylation | KERLEKRYQDIIHSI HHHHHHHHHHHHHHH | 22.93 | 28152594 | |
| 1043 | Acetylation | RKPNLGLKSCDGNQE CCCCCCCCCCCCCHH | 47.44 | 26051181 | |
| 1043 | Sumoylation | RKPNLGLKSCDGNQE CCCCCCCCCCCCCHH | 47.44 | 28112733 | |
| 1043 | Ubiquitination | RKPNLGLKSCDGNQE CCCCCCCCCCCCCHH | 47.44 | - | |
| 1045 | Glutathionylation | PNLGLKSCDGNQELL CCCCCCCCCCCHHHH | 8.10 | 22555962 | |
| 1064 (in isoform 2) | Ubiquitination | - | 36.77 | 21890473 | |
| 1068 | Ubiquitination | EVATRLQKGGLGYVE HHHHHHHHCCCCCCE | 60.58 | 22817900 | |
| 1068 (in isoform 1) | Ubiquitination | - | 60.58 | 21890473 | |
| 1078 | Phosphorylation | LGYVEETSEFEARVI CCCCEECCCEEEEEE | 43.50 | - | |
| 1089 | Sumoylation | ARVISLEKLKDFGEC EEEEEHHHHCCHHHH | 67.16 | - | |
| 1089 | Sumoylation | ARVISLEKLKDFGEC EEEEEHHHHCCHHHH | 67.16 | 28112733 | |
| 1089 | Ubiquitination | ARVISLEKLKDFGEC EEEEEHHHHCCHHHH | 67.16 | 23000965 | |
| 1091 | Ubiquitination | VISLEKLKDFGECVI EEEHHHHCCHHHHHH | 63.18 | 23000965 | |
| 1107 | Sumoylation | LQASVIKKFLQGFMA HHHHHHHHHHHHHCC | 39.93 | - | |
| 1107 | Sumoylation | LQASVIKKFLQGFMA HHHHHHHHHHHHHCC | 39.93 | 28112733 | |
| 1116 | Acetylation | LQGFMAPKQKRRKLQ HHHHCCCHHHHHHCC | 59.94 | 7465925 | |
| 1118 | Acetylation | GFMAPKQKRRKLQSE HHCCCHHHHHHCCCC | 61.36 | 7465937 | |
| 1124 | Phosphorylation | QKRRKLQSEDSAKTE HHHHHCCCCCCCCHH | 54.53 | 25627689 | |
| 1127 | Phosphorylation | RKLQSEDSAKTEEVD HHCCCCCCCCHHHCH | 27.84 | 25159151 | |
| 1129 | Sumoylation | LQSEDSAKTEEVDEE CCCCCCCCHHHCHHH | 61.49 | - | |
| 1129 | Acetylation | LQSEDSAKTEEVDEE CCCCCCCCHHHCHHH | 61.49 | 26051181 | |
| 1129 | Sumoylation | LQSEDSAKTEEVDEE CCCCCCCCHHHCHHH | 61.49 | - | |
| 1147 | Phosphorylation | VEEAKVASALEKWKT HHHHHHHHHHHHHHH | 36.05 | 22817900 | |
| 1151 | Ubiquitination | KVASALEKWKTAIRE HHHHHHHHHHHHHHH | 55.64 | - | |
| 1192 | Ubiquitination | ARCKVCRKKGEDDKL CCCCCCCCCCCCCCE | 61.06 | 22505724 | |
| 1193 | Ubiquitination | RCKVCRKKGEDDKLI CCCCCCCCCCCCCEE | 48.45 | 22505724 | |
| 1198 | Ubiquitination | RKKGEDDKLILCDEC CCCCCCCCEEEECCC | 50.15 | 22505724 | |
| 1207 | Ubiquitination | ILCDECNKAFHLFCL EEECCCHHHHHHHHH | 65.18 | 22505724 | |
| 1249 | Phosphorylation | GRNYTEESASEDSED CCCCCCCCCCCCCCC | 30.75 | 25137130 | |
| 1251 | Phosphorylation | NYTEESASEDSEDDE CCCCCCCCCCCCCCC | 51.74 | 25137130 | |
| 1254 | Phosphorylation | EESASEDSEDDESDE CCCCCCCCCCCCCCH | 38.58 | 25137130 | |
| 1259 | Phosphorylation | EDSEDDESDEEEEEE CCCCCCCCCHHHHHH | 58.26 | 25137130 | |
| 1291 | Acetylation | PRKTIRGKHSVIPPA CCCCCCCCCCCCCHH | 23.90 | 26051181 | |
| 1291 | Ubiquitination | PRKTIRGKHSVIPPA CCCCCCCCCCCCCHH | 23.90 | 29967540 | |
| 1293 | Phosphorylation | KTIRGKHSVIPPAAR CCCCCCCCCCCHHHH | 25.81 | 28555341 | |
| 1315 | Phosphorylation | KPHSTRRSQPKAPPV CCCCCCCCCCCCCCC | 47.76 | 23401153 | |
| 1318 | Ubiquitination | STRRSQPKAPPVDDA CCCCCCCCCCCCCHH | 66.92 | 29967540 | |
| 1331 (in isoform 2) | Ubiquitination | - | 3.33 | 21890473 | |
| 1334 | Phosphorylation | VDELVLQTKRSSRRQ HHHHHHHHHHHHHHH | 25.02 | 23312004 | |
| 1335 | Acetylation | DELVLQTKRSSRRQS HHHHHHHHHHHHHHH | 37.00 | 23954790 | |
| 1335 | Ubiquitination | DELVLQTKRSSRRQS HHHHHHHHHHHHHHH | 37.00 | 22817900 | |
| 1335 (in isoform 1) | Ubiquitination | - | 37.00 | 21890473 | |
| 1337 | Phosphorylation | LVLQTKRSSRRQSLE HHHHHHHHHHHHHHH | 29.74 | 21406692 | |
| 1338 | Phosphorylation | VLQTKRSSRRQSLEL HHHHHHHHHHHHHHH | 35.20 | 21406692 | |
| 1342 | Phosphorylation | KRSSRRQSLELQKCE HHHHHHHHHHHHHHH | 23.23 | 29255136 | |
| 1347 | Ubiquitination | RQSLELQKCEEILHK HHHHHHHHHHHHHHH | 57.13 | 29967540 | |
| 1354 | Acetylation | KCEEILHKIVKYRFS HHHHHHHHHHHHHCC | 45.83 | 26051181 | |
| 1354 | Ubiquitination | KCEEILHKIVKYRFS HHHHHHHHHHHHHCC | 45.83 | 29967540 | |
| 1358 | Phosphorylation | ILHKIVKYRFSWPFR HHHHHHHHHCCCCCC | 13.14 | 22210691 | |
| 1361 | Phosphorylation | KIVKYRFSWPFREPV HHHHHHCCCCCCCCC | 25.49 | 22210691 | |
| 1369 | Phosphorylation | WPFREPVTRDEAEDY CCCCCCCCHHHHHHH | 43.02 | 27642862 | |
| 1376 | Phosphorylation | TRDEAEDYYDVITHP CHHHHHHHHHCCCCC | 7.96 | 28796482 | |
| 1377 | Phosphorylation | RDEAEDYYDVITHPM HHHHHHHHHCCCCCC | 18.96 | 28796482 | |
| 1381 | Phosphorylation | EDYYDVITHPMDFQT HHHHHCCCCCCCHHH | 21.56 | 22210691 | |
| 1388 | Phosphorylation | THPMDFQTVQNKCSC CCCCCHHHHCCCCCC | 24.85 | 22210691 | |
| 1431 | Acetylation | HVLSCMVKTEQCLVA CHHHHEECHHHHHHH | 21.33 | 26051181 | |
| 1435 | Glutathionylation | CMVKTEQCLVALLHK HEECHHHHHHHHHHH | 2.41 | 22555962 | |
| 1442 | Acetylation | CLVALLHKHLPGHPY HHHHHHHHHCCCCHH | 46.97 | 26051181 | |
| 1449 | Phosphorylation | KHLPGHPYVRRKRKK HHCCCCHHHHCCCCC | 10.83 | 28258704 | |
| 1468 | Phosphorylation | LAEDEGDSEPEAVGQ HCCCCCCCCHHHHCC | 66.94 | 29255136 | |
| 1476 | Phosphorylation | EPEAVGQSRGRRQKK CHHHHCCCCCCCCCC | 30.67 | 23927012 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BAZ1B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BAZ1B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SMCA5_HUMAN | SMARCA5 | physical | 16603771 | |
| ERCC6_HUMAN | ERCC6 | physical | 16603771 | |
| SF3B1_HUMAN | SF3B1 | physical | 16603771 | |
| RHD_HUMAN | RHD | physical | 16603771 | |
| DEK_HUMAN | DEK | physical | 16603771 | |
| MBB1A_HUMAN | MYBBP1A | physical | 16603771 | |
| MYO1C_HUMAN | MYO1C | physical | 16603771 | |
| VDR_HUMAN | VDR | physical | 17250953 | |
| SMCA5_HUMAN | SMARCA5 | physical | 22939629 | |
| SMRC2_HUMAN | SMARCC2 | physical | 22939629 | |
| TOP2B_HUMAN | TOP2B | physical | 22939629 | |
| SMRC1_HUMAN | SMARCC1 | physical | 22939629 | |
| SMCA4_HUMAN | SMARCA4 | physical | 22939629 | |
| MBD3_HUMAN | MBD3 | physical | 22939629 | |
| SMRD2_HUMAN | SMARCD2 | physical | 22939629 | |
| SRRM2_HUMAN | SRRM2 | physical | 22939629 | |
| SMCA5_HUMAN | SMARCA5 | physical | 23555303 | |
| MYO1C_HUMAN | MYO1C | physical | 23555303 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-426, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-705; SER-1315 ANDSER-1468, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330 AND SER-1468, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330; SER-345; SER-347;SER-349; SER-361; SER-374; SER-699; SER-705; SER-708; SER-716;SER-947; SER-1315; SER-1342 AND SER-1468, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1468, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330; SER-347; SER-349;SER-508; SER-1342 AND SER-1468, AND MASS SPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167, AND MASSSPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-705 AND SER-1468, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189; SER-361; SER-1147;SER-1342 AND SER-1468, AND MASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-705; SER-708 ANDSER-1468, AND MASS SPECTROMETRY. | |